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Abstract
 Background/Objectives—This study aimed to determine the association between a 
Mediterranean diet and glycemic control and other cardiovascular risk factors among youth with 
type 1 diabetes (T1D).
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 Subjects/Methods—Incident T1D cases aged <20 years at diagnosis between 2002 and 2005 
were included. Participants were seen at baseline (N=793), 1-year (N=512) and 5-year follow-up 
visits (N=501). Mediterranean diet score was assessed using a modified KIDMED index 
(mKIDMED). Multivariate linear regression and longitudinal mixed model were applied to 
determine the association between mKIDMED score and log-HbA1c, lipids, blood pressure (BP), 
and obesity.
 Results—In cross-sectional analyses using baseline data, for individuals with an HbA1c of 
7.5%, a two-point higher mKIDMED score (one standard deviation) was associated with 0.15% 
lower HbA1c (P=0.02). A two-point higher mKIDMED score was associated with 4.0 mg/dL 
lower total cholesterol (TC) (P=0.006), 3.4 mg/dL lower low-density lipoprotein (LDL)-C 
(P=0.004), 3.9 mg/dL lower non-high-density lipoprotein (non-HDL)-C (P=0.004), and 0.07 lower 
LDL-C/HDL-C ratio (P=0.02). Using longitudinal data, a two-point increase in mKIDMED score 
was associated with 0.01% lower log-HbA1c (P=0.07), 1.8 mg/dL lower TC (P=0.05), 1.6 mg/dL 
lower LDL-C (P=0.03), and 1.8 mg/dL lower non-HDL-C (P=0.03) than would otherwise have 
been expected. HbA1c mediated about 20% of the association for lipids in both cross-sectional 
and longitudinal models. An unexpected positive association between mKIDMED score and 
systolic BP was found among non-Hispanic white youth in cross-sectional analyses (P=0.009). 
Mediterranean diet was not associated with obesity.
 Conclusions—Mediterranean diet may improve glycemic control and cardiovascular health in 
T1D youth.
 INTRODUCTION
Type 1 diabetes (T1D) is associated with 2–4 fold increased risk in cardiovascular mortality 
and morbidity.1,2 Poor glycemic control is commonly seen in youth with T1D,3 contributing 
further to the risk of cardiovascular diseases (CVD).2,4 Epidemiological evidence and 
autopsy data have revealed that pathological processes and risk factors associated with 
development of atherosclerosis, start early in childhood.2,5 There is an urgent need to devise 
effective management strategies to improve CVD risk profile and glycemic control in youth 
with T1D.3
The American Heart Association (AHA) advises that primary prevention of CVD should 
begin in childhood and that achieving and maintaining a healthy diet is critical.6 Healthful 
dietary patterns are developed in childhood and accrued health benefits track into 
adulthood.7 A systematic review of intervention studies reported an inverse association 
between a Mediterranean diet and dyslipidemia and obesity in adults.8 A Mediterranean diet 
may also be beneficial for blood pressure (BP)9 and hemoglobin A1c (HbA1c) in adults.10 
The recent PREDIMED trial reported a reduction of about 30% in the risk of major 
cardiovascular events among individuals with diabetes who consumed a Mediterranean style 
diet.11 However, whether a Mediterranean diet confers similar benefits on glycemic control 
and CVD risk factors to youth with T1D is unknown. The purpose of the present report is to 
determine the associations of a Mediterranean diet with glycemic control and CVD risk 
factors in youth with T1D, using both cross-sectional and longitudinal data.
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 SUBJECTS AND METHODS
Started in 2001, SEARCH for Diabetes in Youth (SEARCH) is an ongoing multicenter 
epidemiologic study of physician-diagnosed diabetes among youth <20 years at diagnosis.12 
The SEARCH Nutrition Ancillary Study was designed to assess the associations of 
nutritional factors with the progression of insulin secretion defects and CVD risk factors in 
youth with T1D. Both studies were reviewed and approved annually by the local institutional 
review boards that had jurisdiction over the local study population and complied with the 
Health Insurance Portability and Accountability Act. Written informed consent was obtained 
from participants age >18 years or their parents or legal guardians if <18 years.
 Study participants
Participants eligible for inclusion were newly-diagnosed T1D cases before 20 years of age 
between 2002 and 2005. Participants were then invited to attend an initial baseline visit and 
three subsequent visits scheduled at about 1-year, 2-year, and 5-year of follow-up when 
demographic, anthropometric, laboratory and clinical data were collected. Food frequency 
questionnaire (FFQ) data were collected at baseline, 1-year and 5-year visits among those 
aged ≥10 years. During the study period, we did not perform any dietary intervention or 
education on participants. A baseline visit was completed for 1,156 incident T1D cases. 
Youth were sequentially excluded for missing FFQ (N=208), diabetes duration < 3 months 
(N=82), fasting < 8 hours (N=37) and eating much more or much less than typical (N=36) in 
the week covered by the FFQ. The same exclusions were applied to 1-year and 5-year 
follow-up data. The final sample consisted of 793 cases at baseline, 512 at 1-year and 501 at 
5-year visits.
 Outcome measures
Height, weight, waist circumference, and BP were measured according to standardized 
protocol by trained and certified staff. BMI was calculated as weight (kg)/height squared 
(m2) and converted to a BMI z score.13 Blood samples were collected under metabolic 
stability conditions, defined as no episode of diabetic ketoacidosis within 1 month before the 
visit, and after ≥8 hours of fasting. All samples were processed at the local site and then 
shipped within 24 hours to the central laboratory where specimens were assayed for HbA1c, 
total cholesterol (TC), triglycerides, and high-density lipoprotein (HDL)-C, low-density 
lipoprotein (LDL)-C and apolipoprotein B. Non-HDL-C was calculated as TC minus HDL-
C. The standardized measurement and assay protocol for the SEARCH study was previously 
described.14 The same standardized protocol was applied to all three visits. Apolipoprotein 
B was not assayed at follow-up visits.
 Dietary assessment and modified KIDMED (mKIDMED) score
Dietary intake was obtained via a FFQ. The details of the SEARCH FFQ and its validation 
were described elsewhere.15,16 Briefly, the FFQ contained 85 food lines. Participants 
reported whether the item(s) was consumed in the past week, on how many days, and in 
what average portion size which was queried for each line item either as a number (e.g., 
number of slices of bread) or relative to pictures of food in bowls or plates. In our validation 
study on a subgroup of 172 participants, we collected FFQ twice and used three 24-hour 
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recalls to validate dietary data from FFQ. The mean correlations of food groups and 
nutrients between the FFQ and true usual intake were 0.41 and 0.38, respectively. Reliability 
of FFQ intake was with 54 % of Pearson correlation coefficients ≥0.5.16 The FFQ was 
primarily self-administered after participants were instructed by trained and certified staff. 
Interview administration was given if necessary.
The KIDMED index developed by Serra-Majem et al.17 has been widely used to evaluate a 
Mediterranean diet among children and adolescents. The KIDMED index was based on a 
16-question survey designed to reflect the principles sustaining the Mediterranean dietary 
pattern and those that undermine it.17 The SEARCH FFQ was not originally designed for 
assessing Mediterranean diet through the KIDMED index and thus 5 modifications were 
necessary. First, because we did not query meal-specific intake, we used dietary intake in a 
whole day to reflect items specified for consumption at breakfast in the original KIDMED 
index. Second, we dropped the “skipping breakfast” item because there was no reliable way 
to impute this from our data. Third, SEARCH FFQ did not query for use of olive oil at 
home. This item was replaced with the monounsaturated fatty acids (MUFA)/saturated fatty 
acids (SFA) ratio, which has been widely used to characterize a Mediterranean diet in both 
the US and European populations.18,19 Fourth, one time/day in the KIDMED index was 
translated into one serving/day while >1 times/day was treated as ≥two servings/day in the 
mKIDMED index. Fifth, potato consumption was excluded from the vegetable group due to 
the possibility of including French fries or potato chips.18 Accordingly, we modified the 16-
item KIDMED index into the 15-item mKIDMED index. Items denoting a negative 
connotation with respect to a Mediterranean diet were assigned a value of −1 while those 
with a positive aspect were scored +1. The score range of the mKIDMED index was from −3 
to 12. Low, median and high Mediterranean diet score was defined as having a mKIDMED 
score of ≤3, 4–7 and ≥8, respectively.17
 Statistical Analysis
Outcome variables with skewed distribution were log transformed (HbA1c and 
triglycerides). Mean and standard deviation (SD) were presented for normally distributed 
variables. Analysis of Variance (ANOVA) was used to evaluate the differences of each 
variable across the three Mediterranean diet categories (low, median and high). For variables 
that were non-normally distributed, the median and interquartile range (IQR) were presented 
and Kruskal Wallis test was applied to evaluate the differences. Categorical variables were 
examined using chi-square test.
HbA1c and BMI z score were explored as potential mediators20 a priori for the association 
between a Mediterranean diet and CVD risk factors. Gender and race/ethnicity (non-
Hispanic white versus “other”) were evaluated as potential effect modifiers. Effect 
modification was assessed before the main effect. If effect modification variables were not 
significant (P >0.05), potential effect modifier(s) would be included as confounder(s). 
Additional confounders were age, duration of diabetes, parental education, family income, 
parental history of diabetes, study site, physical activity, sedentary behavior, smoking, total 
calories from FFQ, insulin regimen, and daily insulin dose per kilogram. Height was 
additionally adjusted for BP.
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Baseline outcome data were modeled using a series of multivariate linear regressions, 
sequentially adjusting for non-modifiable confounders, modifiable confounders and 
mediators. To determine the association between the change in mKIDMED score across 
visits and glycemic control and CVD risk factors, repeatedly measured data were analyzed 
using mixed-models with a random intercept and random time-effect to account for within-
subject dependence. Mixed models explicitly model individual-level change across time and 
are flexible in terms of repeated measures.21 All tests were conducted at a significance level 
of 0.05. Results were interpreted in terms of a two-point difference in mKIDMED score, 
which was approximately equal to one SD of the mKIDMED score. Data analyses were 
performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC).
 RESULTS
Only 2.8% of the 793 participants at baseline had high Mediterranean diet score while 
45.8% had a median score and 51.5% had a low score (Table 1). There were no statistically 
significant differences between three Mediterranean diet categories in terms of age, gender, 
diagnosis age, duration of diabetes, race/ethnicity; a difference was seen for parental 
education (P=0.04). In these unadjusted analyses, TC and LDL-C were inversely associated 
with Mediterranean diet score, and higher score was associated with higher physical activity 
level. The distribution of the three Mediterranean diet categories was similar at baseline, 1-
year and 5-year follow-up visits (Figure 1). The distribution of the mKIDMED score 
changed little over time (Figure 2, P=0.23). There was considerable individual-level change 
in mKIDMED score between different visits, but no difference in the distribution of the 
change was observed (Figure 3, P=0.84).
Models of cross-sectional associations between Mediterranean diet score and glycemic 
control and CVD risk factors are displayed in Table 2. In the fully-adjusted Model 2, a two-
point higher mKIDMED score was associated with 4.0 mg/dL lower TC (P=0.006), 3.4 
mg/dL lower LDL-C (P=0.004), 3.9 mg/dL lower non-HDL-C (P=0.004), and 0.07 lower 
LDL-C/HDL-C ratio (P=0.02). Due to the log-transformation of HbA1c for modeling, the 
mean value of HbA1c (about 8.0%; data not shown) in the sample was used for interpreting 
the result. Specifically, for an individual with an HbA1c level of 7.5%, a two-point higher 
mKIDMED score was associated with 0.15% lower HbA1c (P=0.02). Mediterranean diet 
was not associated with log-triglycerides, apolipoprotein B, BMI z score or waist 
circumference.
Effect modification by race/ethnicity was found for systolic BP (Model 2, P=0.03) at 
baseline. A two-point higher mKIDMED score was associated unexpectedly with 1.2 mm 
Hg higher systolic BP (P=0.009) among non-Hispanic white youth, while systolic BP was 
0.8 mm Hg lower but not significant (P=0.34) among children with “other” race/ethnicity. 
Gender was not an effect modifier for any outcomes. No association was found for diastolic 
BP.
Results from longitudinal mixed models are shown in Table 3. Based on the fully-adjusted 
Model 2, a two-point increase in mKIDMED score was associated with 1.8 mg/dL lower TC 
(P=0.05), 1.6 mg/dL lower LDL-C (P=0.03), and 1.8 mg/dL lower non-HDL-C (P=0.03) 
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than would otherwise have been expected. For an individual with an HbA1c of 7.5% at one 
visit, his/her HbA1c would be dropped to 7.43% (P=0.07) for a two-point increase in 
mKIDMED score at the next visit. No association was found between mKIDMED score and 
HDL-C, LDL-C/HDL-C ratio, log-triglycerides, BP, BMI z score or waist circumference.
HbA1c mediated about 20% of the associations for lipids both in cross-sectional (P=0.02) 
and longitudinal models (P=0.07). BMI z score attenuated ≤8% of the associations for lipids 
both in baseline and longitudinal models 
 DISCUSSION
Our study revealed that a very low percentage of youth adhered to a Mediterranean style diet 
in this large incident T1D cohort in the US. Higher Mediterranean diet score was cross-
sectionally associated with lower HbA1c and improved lipid profile. Increased 
Mediterranean diet score across time was longitudinally associated with improved lipid 
profile and marginally improved HbA1c. Additionally, HbA1c mediated about 20% of the 
effect of a Mediterranean diet on lipids.
In SEARCH, beneficial associations between the Dietary Approaches to Stop Hypertension 
(DASH) diet and CVD risk factors and glycemic control were reported among T1D 
youth.14,22,23 A favorable association was found between the DASH diet and lipids only in 
cross-sectional analyses while, reported herein, a Mediterranean diet was inversely 
associated with lipids both cross-sectionally and longitudinally. Of note, the previous 
longitudinal analyses of the DASH diet had a markedly smaller sample.23 The DASH diet 
and Mediterranean diet were beneficial for HbA1c in both cross-sectional and longitudinal 
analyses.14,23 The DASH diet was inversely associated with hypertension,22 whereas such a 
beneficial effect on hypertension was not observed for a Mediterranean diet in our study. 
Although similar food groups comprise both dietary patterns, there are subtle differences 
that may explain disparate findings between two diets. The type of fats consumed is 
emphasized in the mKIDMED index and fast food consumption is scored into the 
mKIDMED index, but not the DASH diet score. Fruit and vegetable intake are emphasized 
to a greater extent in the mKIDMED index with a total of four scored items compared to two 
in the DASH diet score. The benefits of increased MUFA/SFA ratio,24 fruits and 
vegetables,25 and detrimental effect of fast foods,26 on CVD risk factors have been well 
documented.
We found significant inverse associations between a Mediterranean diet and TC, LDL-C and 
non-HDL-C in both cross-sectional and longitudinal models. The lipid-lowering effect of a 
Mediterranean diet on children was previously reported. In a 6-month prospective cohort 
study of 96 children with T1D following a structured dietitian training to a Mediterranean 
diet,27 the reduction of LDL-C and non-HDL-C for about 9 mg/dL was similar to our cross-
sectional results, if the mKIDMED score was increased from a mean score of 3.6 to the 
lowest score of 8 in the high mKIDMED score category (Calculation details: The betas for 
LDL-C and non-HDL-C were −3.39 mg/dL and −3.86 mg/dL, respectively, which was based 
on an increase of mKIDMED score of 2 (Table 2). A 4.4 increase in mKIDMED score 
would be associated with 7.46 mg/dL lower LDL-C and 8.49 mg/dL lower non-HDL-C.). 
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However, in a 12-month Mediterranean diet intervention on 36 pre-pubertal 
hypercholesterolemic children,28 the reduction of TC and LDL-C was about 25 mg/dL, 
much greater than the reduction in our study. Of note, the mean baseline TC level (260.6 
versus 159 mg/dL) and LDL-C level (182.0 versus 93.3 mg/dL) were much higher among 
hypercholesterolemic children as compared to those in our study participants. We found that 
about 20% of the association with lipids was mediated by HbA1c in both cross-sectional and 
longitudinal models. It has been shown that, in youth with T1D, improved HbA1c over a 
two-year follow-up was associated with improved lipid profile.29 BMI z score was not a 
mediator in our data. There may be additional pathways linking a Mediterranean diet with 
lipids independent of HbA1c and weight.
The reduction of HbA1c by about 0.1–0.2% in youth with T1D was very similar between 
DASH and Mediterranean diets in SEARCH,14,23 which was smaller than that from a meta-
analysis of randomized trials (0.47%, 95% confidence interval: 0.30–0.64%)30 and 
observational studies31 in adult type 2 patients. A 6-month structured dietitian training on 
T1D children to a Mediterranean diet improved HbA1c by about 0.2% in males, but not in 
females.27 Thus, a somewhat smaller effect on HbA1c was consistently observed in T1D 
children. The complex impact of macronutrients in the context of various dietary patterns on 
glycemic excursions post meal in T1D is not well understood.32 Thus, the full benefits of 
either the DASH or Mediterranean diet will not be realized until appropriate insulin dosing 
for these diets could be designed.
An unexpected positive association between a Mediterranean diet and systolic BP was 
identified using baseline data among non-Hispanic white youth, but not among youth with 
other racial/ethnic backgrounds. In children, evidence is scant and inconsistent regarding the 
association between a Mediterranean diet and BP.33,34 Two studies also found a positive 
association for systolic BP: Giannini et al.28 did not discuss this finding; the Leontio 
Lyceum Albuminuria (3L) Study34 hypothesized that obesity-related increase in systolic BP 
exceeds Mediterranean diet’s hemodynamically favorable effects in children. However, 
systolic BP still remained significant after accounting for BMI in the 3L study, as in our 
study. In adults, the BP-lowering effect of a Mediterranean diet9 was similar to the 
unrestricted-sodium DASH diet,35 but was less than the restricted-sodium DASH diet.36 
None of the studies in children discussed considered the effect of dietary sodium on the 
association with BP, which may be one of main reasons for the inconsistent or unexpected 
findings. The SEARCH FFQ was not intended to assess sodium intake and did not include 
important sources of sodium in the diet (e.g., use of salt at the table).
The main strengths of our study were a large sample of T1D cases with follow-up data up to 
5 years, inclusion of only incident cases to avoid confounding by factors associated with 
disease duration, extensive control of confounding and careful assessment of mediation and 
effect modification. Limitations should also be noted. First, although the SEARCH FFQ 
itself was validated,16 the original KIDMED index could not be exactly replicated. Thus, the 
derived mKIDMED score may not perfectly represent traditional Mediterranean dietary 
pattern. However, our approach to generate this score was consistent with that of other 
investigators.18,19 Second, some misclassification of the Mediterranean diet score was 
possible due to the assessment of dietary intake by a FFQ. However, it is unlikely that such 
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misclassification would be differential as regard to the outcomes evaluated.14 Third, loss-to 
follow-up may have influenced our findings. However, participants who had one visit only 
were not different from those with one or two additional follow-up visits, in terms of age, 
gender, duration of diabetes, family history of diabetes, insulin dosage, smoking status, BMI 
z score and total daily dietary energy (Appendix Table 1). Fourth, only a small number of 
participants had high mKIDMED score, so we were unable to explore the threshold effect at 
high end of the mKIDMED score if such existed. Finally, we did not explicitly adjust for 
multiple comparisons. Given the large number of associations studied, we cannot ignore the 
possibility that some associations may be the result of type 1 error. The interpretation of 
these findings should consider both their theoretical grounding and results of the previous 
studies.23,27,28,34
In conclusion, higher Mediterranean diet score was associated with better glycemic control 
and lipid profile in youth with T1D. The effect of a Mediterranean diet on lipids was 
mediated in part through HbA1c. Randomized clinical trials are warranted to confirm the 
beneficial effects of a Mediterranean diet on glycemic control and lipids in T1D youth. Such 
trials need to carefully address issues related to insulin dosing and day-to-day glycemic 
control in the context of a Mediterranean diet, and need to address dietary sodium with 
respect to BP outcomes.
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Figure 1. 
The Mediterranean diet score assessed by the mKIDMED index at baseline, 1-year follow-
up, and 5-year follow-up visits. Low, median and high quality had a mKIDMED score of ≤3, 
4–7 and ≥8, respectively.
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Figure 2. 
The distribution of the mKIDMED score at baseline, 1-year follow-up, and 5-year follow-up 
visits (P=0.23). From top to bottom: maximum, 95th percentile, 75th percentile, median, 25th 
percentile, 5th percentile and minimum. P value based on Kruskal Wallis test.
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Figure 3. 
The distribution of the individual level change in mKIDMED score between three visits 
(P=0.84). From top to bottom: maximum, 95th percentile, 75th percentile, median, 25th 
percentile, 5th percentile and minimum. P value based on Kruskal Wallis test.
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